Lin Zhong

951 total citations · 2 hit papers
21 papers, 523 citations indexed

About

Lin Zhong is a scholar working on Pulmonary and Respiratory Medicine, Molecular Biology and Oncology. According to data from OpenAlex, Lin Zhong has authored 21 papers receiving a total of 523 indexed citations (citations by other indexed papers that have themselves been cited), including 8 papers in Pulmonary and Respiratory Medicine, 7 papers in Molecular Biology and 6 papers in Oncology. Recurrent topics in Lin Zhong's work include Cancer-related molecular mechanisms research (6 papers), MicroRNA in disease regulation (3 papers) and Ferroptosis and cancer prognosis (3 papers). Lin Zhong is often cited by papers focused on Cancer-related molecular mechanisms research (6 papers), MicroRNA in disease regulation (3 papers) and Ferroptosis and cancer prognosis (3 papers). Lin Zhong collaborates with scholars based in China, United States and Thailand. Lin Zhong's co-authors include Junjian Wang, Xiaolei Zhang, Linlin Lou, Jianzheng Zhu, Min Li, Wen Ding, Zhenhua Zhang, Peibin Yue, Yuanxiang Wang and Huaxuan Li and has published in prestigious journals such as Molecular Cancer, Signal Transduction and Targeted Therapy and Cell Death and Disease.

In The Last Decade

Lin Zhong

17 papers receiving 519 citations

Hit Papers

Inhibition of STAT3-ferroptosis negative regulatory axis ... 2022 2026 2023 2024 2022 2024 100 200 300
What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

  1. Inhibition of STAT3-ferroptosis negative regulatory axis suppresses tumor growth and alleviates chemoresistance in gastric cancer
    2022 323 citations Shumin Ouyang, Huaxuan Li et al. Redox Biology profile →
  2. Drug resistance in ovarian cancer: from mechanism to clinical trial
    2024 79 citations Ling Wang, Xin Wang et al. Molecular Cancer profile →

Peers

Lin Zhong
Luyang Wang China
Yanlong Shi China
Shibo Yu China
Liming Gui China
Zijie Cai China
Un-Jung Yun South Korea
Amirabbas Kakavand Iran
Junyi Hou China
Mona Joudi Mashhad Iran
Luyang Wang China
Lin Zhong
Citations per year, relative to Lin Zhong Lin Zhong (= 1×) peers Luyang Wang

Countries citing papers authored by Lin Zhong

Since Specialization
Citations

This map shows the geographic impact of Lin Zhong's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Lin Zhong with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Lin Zhong more than expected).

Fields of papers citing papers by Lin Zhong

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Lin Zhong. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Lin Zhong. The network helps show where Lin Zhong may publish in the future.

Co-authorship network of co-authors of Lin Zhong

This figure shows the co-authorship network connecting the top 25 collaborators of Lin Zhong. A scholar is included among the top collaborators of Lin Zhong based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Lin Zhong. Lin Zhong is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Yao, Hua-Dong, Ling Huang, Ying Liu, et al.. (2025). Engineering anti-inflammatory magnesium-mangiferin hydrogel for diabetic wound healing. Materials & Design. 258. 114650–114650. 1 indexed citations
2.
Gui, Long, et al.. (2025). CHST1 as a prognostic-related biomarker in gastric cancer correlating with immune infiltration. Heliyon. 11(3). e42124–e42124. 2 indexed citations
3.
Zhong, Lin, Ying Li, Zhiming Hu, et al.. (2025). Serum Krebs von den Lungen-6 as a potential biomarker for early diagnosis of silicosis: a case-control study. BMC Pulmonary Medicine. 25(1). 366–366.
4.
Qiu, Chong, Pengbo Guo, Lin Zhong, et al.. (2025). Synergistic gambogic acid/Ga³⁺ remodels the immunosuppressive tumor microenvironment to enhance triple-negative breast cancer therapy. Journal of Nanobiotechnology. 23(1). 710–710. 1 indexed citations
5.
Xu, Shuhang, et al.. (2025). Impact of knowledge-attitude-practice model nursing based on reproductive health education on patients with reproductive tract infections. European Journal of Obstetrics & Gynecology and Reproductive Biology. 313. 114593–114593.
6.
Zhou, Weiwei, Wei Hui, Arshad Mehmood, et al.. (2024). Countermeasures and management schemes for improving the quality of continuing medical education in hospitals. Perioperative Care and Operating Room Management. 37. 100440–100440.
7.
Xue, Fei, Cheng Cheng, Wenhai Sui, et al.. (2024). Cardiomyocyte-specific knockout of ADAM17 alleviates doxorubicin-induced cardiomyopathy via inhibiting TNFα–TRAF3–TAK1–MAPK axis. Signal Transduction and Targeted Therapy. 9(1). 273–273. 16 indexed citations
8.
Wang, Ling, Xin Wang, Lin Zhong, et al.. (2024). Drug resistance in ovarian cancer: from mechanism to clinical trial. Molecular Cancer. 23(1). 66–66. 79 indexed citations breakdown →
9.
10.
Han, Fanghai, et al.. (2024). Artificial Intelligence Recognition System of Pelvic Autonomic Nerve During Total Mesorectal Excision. Diseases of the Colon & Rectum. 68(3). 308–315. 2 indexed citations
11.
12.
Ma, Shuai, Yiwei Hu, Xiaojuan Wang, et al.. (2023). Marine fungus-derived alkaloid inhibits the growth and metastasis of gastric cancer via targeting mTORC1 signaling pathway. Chemico-Biological Interactions. 382. 110618–110618. 8 indexed citations
13.
Zhong, Guangyu, Lin Zhong, Shuai Ma, et al.. (2023). Hsa_circ_0020134 promotes liver metastasis of colorectal cancer through the miR-183-5p-PFN2-TGF-β/Smad axis. Translational Oncology. 39. 101823–101823. 8 indexed citations
14.
Zhong, Guangyu, et al.. (2023). FMO family may serve as novel marker and potential therapeutic target for the peritoneal metastasis in gastric cancer. Frontiers in Oncology. 13. 1144775–1144775. 5 indexed citations
15.
Zhong, Lin, Bin Yang, Zhenhua Zhang, et al.. (2022). Targeting autophagy peptidase ATG4B with a novel natural product inhibitor Azalomycin F4a for advanced gastric cancer. Cell Death and Disease. 13(2). 161–161. 27 indexed citations
16.
Xu, Yang, Zhihong Zhang, Guangyu Zhong, et al.. (2022). A novel prognostic signature based on cuproptosis-related lncRNA mining in colorectal cancer. Frontiers in Genetics. 13. 969845–969845. 9 indexed citations
17.
Ouyang, Shumin, Huaxuan Li, Linlin Lou, et al.. (2022). Inhibition of STAT3-ferroptosis negative regulatory axis suppresses tumor growth and alleviates chemoresistance in gastric cancer. Redox Biology. 52. 102317–102317. 323 indexed citations breakdown →
18.
Zhong, Lin, et al.. (2020). Intra-arterial injection to create bone metastasis of prostate cancer in mice.. PubMed. 8(4). 93–100. 4 indexed citations
19.
Huang, Jian, Bin Yang, Zhitao Chen, et al.. (2020). Gastric cancer nodal tumour-stroma ratios influence prognosis.. PubMed. 107(13). 1713–1718. 3 indexed citations
20.
Lin, Hui‐Hui, et al.. (2018). Cytotoxicity of Tanshinone IIA combined with Taxol on drug‐resist breast cancer cells MCF‐7 through inhibition of Tau. Phytotherapy Research. 32(4). 667–671. 22 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Luyang Wang Breakdown of academic impact, for papers by Yanlong Shi Breakdown of academic impact, for papers by Shibo Yu Breakdown of academic impact, for papers by Liming Gui Breakdown of academic impact, for papers by Zijie Cai Breakdown of academic impact, for papers by Un-Jung Yun Breakdown of academic impact, for papers by Amirabbas Kakavand Breakdown of academic impact, for papers by Junyi Hou Breakdown of academic impact, for papers by Mona Joudi Mashhad
Rankless by CCL
2026